eHealth, Inc. — Form 8-K
Filed November 4, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
eHealth reported Q3 2026 revenue of $21.3M (down 60% YoY from $53.9M), GAAP net loss of $35.9M (vs $31.7M loss in Q3 2025), and adjusted EBITDA loss of $39.9M (vs $34.0M loss YoY). However, Q3 operating cash flow improved to ($11.2M) from ($25.3M) YoY—a $14.1M improvement. Year-to-date operating cash flow reached $19.6M, up 85% YoY. The company maintained full-year 2026 guidance: revenue $405–$445M, GAAP net income $8–$25M, adjusted EBITDA $55–$75M, operating cash flow ($10)–$12M. Key drivers: intentional reduction in off-season marketing spend; lifetime advisory model showing early positive retention and cross-sell results; commissions receivable up 7% YoY to $970.6M; on track for ~$90M in annual cost reductions ($60M variable, $30M fixed).
Why this rating
Strategic restructuring underway with improving cash flow trend offsetting revenue decline. Within guidance; no material counterparty loss, deal, or restatement. Relative to $126M market cap, this is a deliberate transformation phase, not a crisis or windfall.
See more from November 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.